A deep dive into insomnia management across the lifespan.

Learning Objectives:
– Identify the need to screen and assess a patient presenting with symptoms of insomnia and explain the
link between insomnia and cardiometabolic risk
– Contrast the benefits and risks of the management of insomnia across cardiometabolic patients
– Outline non-prescription and pharmacological options for the management of sleep
– Discuss the role of orexins in sleep-wake regulation, and describe the use of orexin receptor antagonist
class in insomnia treatment